Share-based Payment Arrangement, Expense of Evolent Health, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Evolent Health, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Evolent Health, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $2,396,000.
  • Evolent Health, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $39,739,000, a 0.02% decline year-over-year.
  • Evolent Health, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $39,739,000, a 0.02% decline from 2024.
  • Evolent Health, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $39,746,000, a 1.9% decline from 2023.
  • Evolent Health, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40,501,000, a 19% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Evolent Health, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $39,739,000 $2,396,000 +$8,511,000 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $31,228,000 $14,682,000 +$266,000 +1.8% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $30,962,000 $11,580,000 -$1,079,000 -8.5% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $32,041,000 $11,081,000 -$7,705,000 -41% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $39,746,000 $6,115,000 -$16,718,000 -158% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $56,464,000 $14,416,000 +$4,194,000 +41% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $52,270,000 $12,659,000 +$3,693,000 +41% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $48,577,000 $18,786,000 +$8,076,000 +75% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $40,501,000 $10,603,000 -$4,028,000 -28% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $44,529,000 $10,222,000 +$3,230,000 +46% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $41,299,000 $8,966,000 +$1,954,000 +28% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $39,345,000 $10,710,000 +$5,364,000 +100% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $33,981,000 $14,631,000 +$9,674,000 +195% 01 Oct 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
Q3 2022 $24,307,000 $6,992,000 +$2,597,000 +59% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $21,710,000 $7,012,000 +$3,359,000 +92% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $18,351,000 $5,346,000 +$1,640,000 +44% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $16,711,000 $4,957,000 +$726,000 +17% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
Q3 2021 $15,985,000 $4,395,000 +$1,231,000 +39% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $14,754,000 $3,653,000 -$50,000 -1.4% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $14,804,000 $3,706,000 +$198,000 +5.6% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $14,606,000 $4,231,000 +$3,658,000 +638% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
Q3 2020 $10,948,000 $3,164,000 -$2,594,000 -45% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $13,542,000 $3,703,000 -$1,047,000 -22% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $14,589,000 $3,508,000 -$1,029,000 -23% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 FY
Q4 2019 $15,618,000 $573,000 -$4,476,000 -89% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $20,094,000 $5,758,000 +$1,711,000 +42% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $18,383,000 $4,750,000 +$32,000 +0.68% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $18,351,000 $4,537,000 +$742,000 +20% 01 Jan 2019 31 Mar 2019 10-Q 28 May 2020 2020 Q1
Q4 2018 $17,609,000 $5,049,000 +$784,000 +18% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $16,825,000 $4,047,000 -$1,661,000 -29% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $18,486,000 $4,718,000 -$642,000 -12% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $19,128,000 $3,795,000 -$1,309,000 -26% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $20,437,000 $4,265,000 -$4,393,000 -51% 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $24,830,000 $5,708,000 +$909,000 +19% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $23,921,000 $5,360,000 +$651,000 +14% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $23,270,000 $5,104,000 +$769,000 +18% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $22,501,000 $8,658,000 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $4,799,000 +$417,000 +9.5% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $4,709,000 -$1,445,000 -23% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $4,335,000 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q3 2015 $4,382,000 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $6,154,000 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2

Evolent Health, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $39,739,000 -$7,000 -0.02% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $39,746,000 -$755,000 -1.9% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $40,501,000 +$6,520,000 +19% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $33,981,000 +$17,270,000 +103% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $16,711,000 +$2,105,000 +14% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 $14,606,000 -$1,012,000 -6.5% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $15,618,000 -$1,991,000 -11% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $17,609,000 -$2,828,000 -14% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $20,437,000 -$2,064,000 -9.2% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $22,501,000 +$7,771,000 +53% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $14,730,000 +$14,730,000 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $0 -$1,111,000 -100% 01 Jan 2014 31 Dec 2014 10-K 29 Feb 2016 2015 FY
2013 $1,111,000 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.